Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium hyaluronate injections for subtalar joint osteoarthritis
ACTRN12611000977976Phase 4Completed
- Sponsor
- Meir Medical Center
- Start
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium hyaluronate in Subtalar arthritis (STA), sponsored by Meir Medical Center. Primary endpoint: Ankle Hindfoot Score. Started Sep 2008; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
Subtalar arthritis (STA)
Beyond the preview
Go deeper on ACTRN12611000977976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000977976.